Skip to contentApplication 207797
- Type
- ANDA
- Sponsor
- CHARTWELL RX
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTRATE | CAPSULE;ORAL | EQ 1.5MG BASE | No | No |
| 002 | RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTRATE | CAPSULE;ORAL | EQ 3MG BASE | No | No |
| 003 | RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTRATE | CAPSULE;ORAL | EQ 4.5MG BASE | No | No |
| 004 | RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTRATE | CAPSULE;ORAL | EQ 6MG BASE | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 27241-090 | RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTRATE | Ajanta Pharma Limited | ANDA | Current |
| 27241-091 | RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTRATE | Ajanta Pharma Limited | ANDA | Current |
| 27241-092 | RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTRATE | Ajanta Pharma Limited | ANDA | Current |
| 27241-093 | RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTRATE | Ajanta Pharma Limited | ANDA | Current |